<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05620420</url>
  </required_header>
  <id_info>
    <org_study_id>LY2022-068-A</org_study_id>
    <nct_id>NCT05620420</nct_id>
  </id_info>
  <brief_title>A Multicenter Cross-sectional Study on Mental Health of Patients With Multiple Myeloma</brief_title>
  <official_title>A Multicenter Cross-sectional Study on Mental Health of Patients With Multiple Myeloma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multiple myeloma patients with normal ability of communication and understanding will be&#xD;
      enrolled. DT, GAD-7, PHQ-15 and PSQI scales are designed to assess the mental health status&#xD;
      of the patients. Demographic and disease data of patients will be collected as well. The main&#xD;
      aim is to explore the factors affecting the mental health of myeloma patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 15, 2022</start_date>
  <completion_date type="Anticipated">August 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 15, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>morbidity of psychological distress in patients with multiple myeloma.</measure>
    <time_frame>Baseline (the time when the patient is enrolled to the study)</time_frame>
    <description>The total score of DT scale ≥4 points is defined as obviously psychological distress.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>morbidity of anxiety in patients with multiple myeloma.</measure>
    <time_frame>Baseline (the time when the patient is enrolled to the study)</time_frame>
    <description>GAD-7 scale is applied to assess the anxiety of the patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>morbidity of insomnia in patients with multiple myeloma.</measure>
    <time_frame>Baseline (the time when the patient is enrolled to the study)</time_frame>
    <description>PSQI scale is applied to assess the insomnia of the patient</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Psychological Distress</condition>
  <condition>Insomnia</condition>
  <condition>Somatic Symptoms</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The patients will be recruited form 14 medical centers.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients with symptomatic multiple myeloma were diagnosed according to the criteria of&#xD;
             Chinese multiple myeloma diagnosis and treatment guidelines (revised in 2022).&#xD;
&#xD;
          2. Age ≥18 years, with junior high school education or above. Patients have normal&#xD;
             ability of communication and understanding.&#xD;
&#xD;
          3. Informed consent has been signed.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Who has kinship with other enrolled patients.&#xD;
&#xD;
          2. Life expectancy of&lt; 6 months.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jian Hou</last_name>
    <role>Principal Investigator</role>
    <affiliation>RenJi Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jia Liu</last_name>
    <phone>+86-18918186325</phone>
    <email>liujia1798@renji.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>shanghai Jiaotong University School of Medicine, Renji Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jia Liu</last_name>
      <phone>18918186325</phone>
      <email>liujia1798@renji.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>November 10, 2022</study_first_submitted>
  <study_first_submitted_qc>November 16, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2022</study_first_posted>
  <last_update_submitted>March 28, 2023</last_update_submitted>
  <last_update_submitted_qc>March 28, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>multiple myeloma</keyword>
  <keyword>mental health</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Myeloma</mesh_term>
    <mesh_term>Neoplasms, Plasma Cell</mesh_term>
    <mesh_term>Medically Unexplained Symptoms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

